title: Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.
abstract: Recent studies have demonstrated a role for calcium channel blocking agents in the treatment of persistent hyperinsulinemic hypoglycemia of newborns. We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies. A 4-day-old male infant was referred with intractable hypoglycemia and seziures. Normoglycaemia could be maintained only by the intravenous infusion of glucose at a rate of 20 mg/kg per minute. Persistent hyperinsulinemic hypoglycemia of newborn was diagnosed from an inappropriately raised plasma insulin concentration (44 mU/L) at the time of hypoglycemia. Medical treatments led to only a mild reduction in the intravenous glucose requirement; an 85-90% pancreatectomy was performed and histological "diffuse nesidioblastosis" was confirmed. However, despite all the medical treatments after the first pancreatectomy, the hyperinsulinemic hypoglycemia persisted and a second 95% pancreatectomy was performed. After the second pancreatectomy, persistent hyperinsulinemic hypoglycemia was treated with somatostatin and diazoxide, but led to no reduction in the intravenous glucose requirement. We report the case of an infant who had persistent hypoglycemia after two subtotal pancreatic resections but subsequently became normoglycemic on treatment with nifedipine (2 mg/kg per day). The patient was discharged home on oral nifedipine. Calcium channel blocking agents cuold be used with efficacy and safety in recurrent persistent hyperinsulinemic hypoglycemia.
authors.forename: Esad
authors.initials: E
authors.lastname: Koklu
authors.forename: Keramettin Uğur
authors.initials: KU
authors.lastname: Ozkan
authors.forename: Hamide
authors.initials: H
authors.lastname: Sayar
authors.forename: Selmin
authors.initials: S
authors.lastname: Koklu
authors.forename: Mehmet
authors.initials: M
authors.lastname: Keskin
mesh_terms: D003131:Combined Modality Therapy; D044903:Congenital Hyperinsulinism / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D046768:Nesidioblastosis / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D009543:Nifedipine / Q000627:therapeutic use*
chemical_list: D009543:Nifedipine